Found: 15
Select item for more details and to access through your institution.
Plasma and cellular pharmacology of 8-chloro-adenosine in mice and rats.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 2, p. 85, doi. 10.1007/s00280-002-0456-0
- By:
- Publication type:
- Article
Comparison of the pharmacological profile of an olivacine derivative and a potential prodrug.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 2, p. 95, doi. 10.1007/s00280-002-0481-z
- By:
- Publication type:
- Article
Nephrotoxicity of heptaplatin: a randomized comparison with cisplatin in advanced gastric cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 2, p. 104, doi. 10.1007/s00280-002-0483-x
- By:
- Publication type:
- Article
Osteosarcoma cells, resistant to methotrexate due to nucleoside and nucleobase salvage, are sensitive to nucleoside analogs.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 2, p. 111, doi. 10.1007/s00280-002-0478-7
- By:
- Publication type:
- Article
Anti-Erwinia asparaginase antibodies during treatment of childhood acute lymphoblastic leukemia and their relationship to outcome: a case-control study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 2, p. 117, doi. 10.1007/s00280-002-0466-y
- By:
- Publication type:
- Article
Pentostatin pharmacokinetics and dosing recommendations in patients with mild renal impairment.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 2, p. 121, doi. 10.1007/s00280-002-0468-9
- By:
- Publication type:
- Article
Bcl2-negative MCF7 cells overexpress p53: implications for the cell cycle and sensitivity to cytotoxic drugs.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 2, p. 127, doi. 10.1007/s00280-002-0467-x
- By:
- Publication type:
- Article
STEALTH liposome-encapsulated cisplatin (SPI-77) versus carboplatin as adjuvant therapy for spontaneously arising osteosarcoma (OSA) in the dog: a randomized multicenter clinical trial.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 2, p. 131, doi. 10.1007/s00280-002-0469-8
- By:
- Publication type:
- Article
Clinical trial and pharmacokinetic study of combination paclitaxel and carboplatin in patients with epithelial ovarian cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 2, p. 137, doi. 10.1007/s00280-002-0471-1
- By:
- Publication type:
- Article
Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethyleneglycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 2, p. 143, doi. 10.1007/s00280-002-0463-1
- By:
- Publication type:
- Article
A phase II trial of pyrazoloacridine (PZA) in squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 2, p. 151, doi. 10.1007/s00280-002-0470-2
- By:
- Publication type:
- Article
Phase I/II trial of weekly epidoxorubicin and docetaxel (wED) in the neoadjuvant and palliative treatment of patients with breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 2, p. 155, doi. 10.1007/s00280-002-0476-9
- By:
- Publication type:
- Article
A phase II trial of oral temozolomide in patients with metastatic renal cell cancer.
- Published in:
- 2002
- By:
- Publication type:
- journal article
The chemokine CCL21 protects normal marrow progenitors from Ara-C cytotoxicity.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 2, p. 163, doi. 10.1007/s00280-002-0486-7
- By:
- Publication type:
- Article
c-KIT-expressing Ewing tumour cells are insensitive to imatinib mesylate (STI571).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 2, p. 167, doi. 10.1007/s00280-002-0477-8
- By:
- Publication type:
- Article